Filing Details
- Accession Number:
- 0001225208-17-003334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-15 11:30:12
- Reporting Period:
- 2017-02-14
- Filing Date:
- 2017-02-15
- Accepted Time:
- 2017-02-15 11:30:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601572 | A Rita Karachun | Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033 | Sr. Vp Fince-Global Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-02-14 | 2,954 | $64.73 | 11,675 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Holdings include shares acquired in dividend reinvestment transactions.
Billionaire Hedge Funds
